Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung Cancer

by Katherine B. Sahin, Esha T. Shah, Genevieve P. Ferguson, Christopher Molloy, Priyakshi Kalita-de Croft, Sarah A. Hayes, Amanda Hudson, Emily Colvin, Hannah Kamitakahara, Rozelle Harvie, Csilla Hasovits, Tashbib Khan, Pascal H. G. Duijf, Viive M. Howell, Yaowu He, Emma Bolderson, John D. Hooper, Sunil R. Lakhani, Derek J. Richard, Kenneth J. O’Byrne, Mark N. Adams
Published 2021-09-01